Charles River Laboratories International, Inc. (FRA:RV6)

Market Cap	7.56B
Revenue (ttm)	3.44B
Net Income (ttm)	-71.39M
Shares Out	n/a
EPS (ttm)	-1.43
PE Ratio	n/a
Forward PE	16.66
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	6
Open	154.15
Previous Close	153.85
Day's Range	154.15 - 154.15
52-Week Range	87.70 - 191.30
Beta	n/a
RSI	58.14
Earnings Date	Feb 18, 2026

About FRA:RV6

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use o...

• Industry: Commercial Physical and Biological Research
• Founded: 1947
• Employees: 20,100
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: RV6

Financial Performance

In 2024, FRA:RV6's revenue was $4.05 billion, a decrease of -1.92% compared to the previous year's $4.13 billion. Earnings were $10.30 million, a decrease of -97.83%.

Financial numbers in USD